Drug Profile
Autotaxin
Latest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antineoplastics
- Mechanism of Action Autocrine motility factor stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 08 Mar 2001 No-Development-Reported for Cancer in USA (Unknown route)
- 20 Feb 1997 New profile
- 20 Feb 1997 Preclinical development for Cancer in USA (Unknown route)